BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  TPX-100: OrthoTrophix Presents New Data Suggesting Joint Bone Shape as a Possible Surrogate Marker for Virtual Joint Replacement in Knee Osteoarthritis

  OrthoTrophix, Inc., a privately held biopharmaceutical company, announced that the Company and its collaborators present clinical data strongly supporting joint bone shape change as part of a surrogate marker predictive of joint replacement in knee osteoarthritis patients.

  April 8, 2022

   · 

  3 min read
• Business

  Merck to Hold First-Quarter 2022 Sales and Earnings Conference Call April 28

  Merck, known as MSD outside the United States and Canada, will hold its first-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Thursday, April 28.

  April 8, 2022

   · 

  3 min read